Jeff Yass’s RxSight RXST Stock Holding History

Jeff Yass’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.4K	Sell	11,700 -7,500	-39%	-$45.3K	﹤0.01%	12784
2026 Q1	$118K	Buy	+19,200	New	+$159K	﹤0.01%	12225
2025 Q1	–	Sell	-6,400	Closed	-$220K	–	13316
2024 Q4	$220K	Sell	6,400 -10,200	-61%	-$460K	﹤0.01%	10507
2024 Q3	$821K	Buy	+16,600	New	+$850K	﹤0.01%	7290
2024 Q1	–	Sell	-13,800	Closed	-$556K	–	13188
2023 Q4	$556K	Buy	+13,800	New	+$405K	﹤0.01%	8390

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jeff Yass's RXST Position: Q2 2026 in Review

Jeff Yass reduced its RxSight (RXST) stake by 57% in Q2 2026, selling an estimated $242K and leaving 30,238 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #12228.

Jeff Yass first reported a position in RXST in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.57M in Q2 2023. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Jeff Yass held 30,238 shares of RxSight worth $146K as of Q2 2026.
Jeff Yass sold 40,055 RxSight shares in Q2 2026, an estimated $242K.
RxSight made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12228 holding.
Jeff Yass first reported a position in RxSight in Q1 2022 and has held it in 15 quarters since.
Jeff Yass's RxSight position peaked at $1.57M in Q2 2023.
150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.